Logo image of ACAC

ACRI CAPITAL ACQUISITION COR (ACAC) Stock Fundamental Analysis

NASDAQ:ACAC - Nasdaq - US00501A1016 - Common Stock - Currency: USD

11.2  -1.75 (-13.51%)

After market: 11.3 +0.1 (+0.89%)

Fundamental Rating

1

ACAC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of ACAC have multiple concerns. ACAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACAC had positive earnings in the past year.
ACAC had a negative operating cash flow in the past year.
ACAC Yearly Net Income VS EBIT VS OCF VS FCFACAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K

1.2 Ratios

Industry RankSector Rank
ROA 1.35%
ROE 1.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACAC Yearly ROA, ROE, ROICACAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2

1.3 Margins

ACAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACAC Yearly Profit, Operating, Gross MarginsACAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

ACAC has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ACAC has a worse debt to assets ratio.
ACAC Yearly Shares OutstandingACAC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
ACAC Yearly Total Debt VS Total AssetsACAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M

2.2 Solvency

ACAC has an Altman-Z score of 3.88. This indicates that ACAC is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.16 indicates that ACAC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 3.88
ROIC/WACCN/A
WACCN/A
ACAC Yearly LT Debt VS Equity VS FCFACAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

ACAC has a Current Ratio of 0.02. This is a bad value and indicates that ACAC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that ACAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ACAC Yearly Current Assets VS Current LiabilitesACAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ACAC have decreased strongly by -50.47% in the last year.
EPS 1Y (TTM)-50.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-367.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAC Yearly Revenue VS EstimatesACAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 100M 200M 300M 400M
ACAC Yearly EPS VS EstimatesACAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 0.1 0.2 0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 280.00 indicates a quite expensive valuation of ACAC.
ACAC is valuated expensively when we compare the Price/Earnings ratio to 26.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 280
Fwd PE N/A
ACAC Price Earnings VS Forward Price EarningsACAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACAC Per share dataACAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACRI CAPITAL ACQUISITION COR

NASDAQ:ACAC (9/26/2024, 8:00:00 PM)

After market: 11.3 +0.1 (+0.89%)

11.2

-1.75 (-13.51%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.73%
Inst Owner Change-85.75%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap44.46M
Analysts100
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 280
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.87
P/tB 2.87
EV/EBITDA N/A
EPS(TTM)0.04
EY0.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE 1.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 3.88
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-367.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.86%
OCF growth 3YN/A
OCF growth 5YN/A